Polly Preventza is a Managing Director at DelMorgan & Co., with over 13 years of professional experience as an investment banker advising clients on mergers and acquisitions and corporate finance transactions. In her career, Ms. Preventza has advised clients on over $60 billion of M&A and financing transactions, working with both public and private companies and with a particular focus and expertise in the healthcare industry. Prior to joining DelMorgan, Ms. Preventza was the founder and President of MPL Advisors Inc., a boutique investment banking advisory firm based in Los Angeles, California. Prior to founding MPL Advisors, Ms. Preventza was a Principal at the Banc of America / Merrill Lynch Investment Banking group in New York, specializing in M&A of healthcare companies. Her industry expertise spanned all sectors of the industry, including specialty pharmaceutical companies, medical devices and healthcare services companies.
Ms. Preventza has worked on a wide range of transactions, including Cardinal’s spinoff of CareFusion ($4.7Bn), WellPoint’s divestiture and sale of its Pharmacy Benefit Management business unit to Express Scripts ($4.7Bn), Alpharma’s sale and defense against the hostile bid by King Pharmaceuticals ($1.6Bn), and Boston Scientific’s multiple divestitures, several leveraged buyouts, and successful capital raises for companies in the healthcare, technology, telecommunications, real estate, consumer finance and gaming industries.
Prior to joining Banc of America/Merrill Lynch, Ms. Preventza worked at Morgan Stanley Corporate Finance in Los Angeles and at Lehman Brothers Investment Banking in New York.
Ms. Preventza holds a Ph.D. and a Master’s of Science in Electrical Engineering from Caltech University in Pasadena, with a minor concentration in Finance, and a B.A degree in Electrical Engineering from National Technical University of Athens, Greece with highest honors.
Ms. Preventza has also completed all three levels of the Chartered Financial Analyst (CFA) program.